OLD National Bancorp IN Acquires 234 Shares of Integer Holdings Co. (NYSE:ITGR)

OLD National Bancorp IN grew its holdings in shares of Integer Holdings Co. (NYSE:ITGR) by 10.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 2,375 shares of the medical equipment provider’s stock after acquiring an additional 234 shares during the period. OLD National Bancorp IN’s holdings in Integer were worth $309,000 as of its most recent SEC filing.

A number of other hedge funds also recently modified their holdings of the business. Contravisory Investment Management Inc. raised its position in Integer by 55.9% during the 3rd quarter. Contravisory Investment Management Inc. now owns 223 shares of the medical equipment provider’s stock worth $29,000 after purchasing an additional 80 shares during the last quarter. Quest Partners LLC increased its stake in shares of Integer by 3,688.9% in the second quarter. Quest Partners LLC now owns 341 shares of the medical equipment provider’s stock valued at $39,000 after buying an additional 332 shares during the period. GAMMA Investing LLC raised its position in shares of Integer by 60.9% during the second quarter. GAMMA Investing LLC now owns 375 shares of the medical equipment provider’s stock worth $43,000 after acquiring an additional 142 shares during the last quarter. Headlands Technologies LLC acquired a new position in shares of Integer in the first quarter worth approximately $106,000. Finally, Innealta Capital LLC bought a new stake in Integer in the second quarter valued at approximately $110,000. Institutional investors and hedge funds own 99.29% of the company’s stock.

Insiders Place Their Bets

In other news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total transaction of $1,431,133.60. Following the completion of the transaction, the director now directly owns 2,280 shares in the company, valued at $272,824.80. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

Several research analysts have issued reports on ITGR shares. Oppenheimer assumed coverage on shares of Integer in a report on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price target for the company. KeyCorp boosted their target price on shares of Integer from $139.00 to $144.00 and gave the company an “overweight” rating in a report on Tuesday, October 15th. Bank of America increased their price target on Integer from $135.00 to $145.00 and gave the stock a “buy” rating in a report on Tuesday, October 1st. Benchmark boosted their price objective on Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research note on Monday. Finally, Truist Financial lifted their target price on Integer from $145.00 to $150.00 and gave the stock a “buy” rating in a report on Monday, October 14th. One analyst has rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $140.14.

Integer Stock Performance

Shares of ITGR opened at $125.58 on Wednesday. The stock has a 50-day moving average of $127.19 and a 200-day moving average of $120.82. Integer Holdings Co. has a one year low of $69.40 and a one year high of $133.53. The company has a debt-to-equity ratio of 0.73, a current ratio of 3.29 and a quick ratio of 1.96. The company has a market cap of $4.21 billion, a PE ratio of 43.45, a P/E/G ratio of 1.86 and a beta of 1.08.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, beating the consensus estimate of $1.24 by $0.06. Integer had a return on equity of 11.48% and a net margin of 6.31%. The firm had revenue of $436.20 million during the quarter, compared to the consensus estimate of $437.00 million. During the same quarter in the previous year, the company posted $1.14 earnings per share. The company’s quarterly revenue was up 9.0% on a year-over-year basis. On average, equities research analysts predict that Integer Holdings Co. will post 5.3 EPS for the current fiscal year.

About Integer

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.